Back to search

Article

Histone Deacetylase Inhibitors for Peripheral T-cell Lymphomas: From Biology to Real-World Therapy

2024-08-12

Abstract excerpt

Histone deacetylase inhibitors (HDACis) are being recognized as a potentially effective treatment approach for peripheral T-cell lymphoma (PTCL), which is a diverse group of aggressive lymphomas with a bleak prognosis. Recent evidence has shown that HDACi are effective in treating PTCL, especially in cases where the disease has relapsed or is resistant to other treatments, and there are few available options. Seve...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
13acc3fa-5d8b-54ad-9449-37715e813260
DOI
10.20944/preprints202408.0744.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Histone Deacetylase Inhibitors for Peripheral T-cell Lymphomas: From Biology to Real-World TherapyDOI 10.20944/preprints202408.0744.v1
Select a neighboring publication to make it the new centre.